Blog - Techseriesinsight

December 20, 2024
Business Wire
Healthcare

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Meaningful Insights Biotech Analytics (MiBA), an innovative healthcare technology company, today announced a unique partnership aimed at optimizing...

December 19, 2024
tsi_admin
Insights

API Security Revolutionized: Salt Security & CrowdStrike Integration Unveiled

This announcement details a significant partnership between Salt Security, a prominent player in the API security space, and CrowdStrike, a leading cybersecurity company. The key takeaway is the integration...

December 19, 2024
Business Wire
Biotechnology

Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease

Prothena Corporation plc (NASDAQ:PRTA), today announced results from the Phase IIb PADOVA study conducted by partner Roche investigating prasinezumab in 586 people with early-stage Parkinson’s disease, treated for a...

December 19, 2024
PRNewswire
Healthcare

Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare

Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a pioneer in Internet healthcare solutions, announced a strategic alliance with Bristol Myers Squibb (“BMS”) China on December 16th. The partnership was officially formalized with the...

December 19, 2024
PRNewswire
Healthcare

BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic’s PyroGlutamate-amyloid-beta antibody program

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that it has entered into a global exclusive license agreement with Bristol Myers Squibb (NYSE: BMY) for BioArctic’s PyroGlutamate-amyloid-beta (PyroGlu-Aβ) antibody program, including BAN1503 and...

December 19, 2024
Business Wire
Business Broadcast

Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA

Dong-A ST (CEO: Jeong Jae-hoon, KRX: 170900) proudly announces that its Stelara biosimilar, IMULDOSA (Project Name: DMB-3115, Active Ingredient: Ustekinumab), has received marketing authorization from the European Commission (EC) as of December...

December 19, 2024
Business Wire
Storage

Energy Dome and ENGIE Sign Pioneering Storage Offtake Agreement

As part of the global transition from research to commercial deployment of cleantech technologies, Energy Dome, a visionary long-duration energy storage (LDES) technology company, and ENGIE a global reference...

December 19, 2024
PRNewswire
Press Release

Infosys Achieves Binding Corporate Rules Certification from EU Data Protection Authorities

Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has obtained regulatory approvals for its Binding Corporate Rules (BCR) from the Hesse Data...

December 19, 2024
Business Wire
Cloud

Ukraine Conflict Impacting Nordics Cloud Adoption

The conflict in Ukraine has intensified supply chain disruptions, affecting IT investments across the Nordics, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III),...

December 19, 2024
PRNewswire
Biotechnology

Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced they have entered into a license agreement allowing...